局部晚期非小细胞肺癌碳离子放疗中图像引导的骨匹配与肿瘤匹配比较
本研究纳入40例局部晚期非小细胞肺癌患者,基于复评CT分别采用肿瘤匹配(TM)与骨匹配(BM)重新计算剂量分布Plan-T与Plan-B,并与原计划Plan-O比较。结果显示iGTV V95%中位数Plan-O为100%、Plan-T为99.93%、Plan-B为99.60%,差异有统计学意义;TM靶区剂量覆盖优于BM,肿瘤位移较大时优势更明显,且TM对肿瘤形态变化耐受性更好。
要点
- 40例局部晚期非小细胞肺癌患者中,TM的靶区剂量覆盖优于BM。
- iGTV V95%中位数Plan-O 100%、Plan-T 99.93%、Plan-B 99.60%,差异有统计学意义。
- 肿瘤位移较大时TM靶区覆盖更优,且TM对肿瘤形态变化耐受性更好。
核心结论
- TM的靶区剂量覆盖优于BM,尤其在肿瘤位移较大的情况下。
- TM对肿瘤形态变化表现出更好的耐受性。
研究设计与样本
- 纳入40例诊断为局部晚期非小细胞肺癌的患者。
- 基于患者复评CT图像分别采用TM与BM重新计算,生成Plan-T与Plan-B,并与原剂量分布Plan-O比较。
- 采用剂量-体积参数评估iGTV接受大于95%处方剂量的百分比(V95%),统计分析采用配对符号秩和检验。
- 研究还探讨了肿瘤位移、体积变化和旋转误差对靶区剂量覆盖的影响。
主要发现
- Plan-O、Plan-T和Plan-B组的iGTV V95%中位数分别为100%、99.93%和99.60%,观察到统计学显著差异。
- TM相比BM表现出更好的靶区剂量覆盖。
- 肿瘤位移较大时TM表现出更好的靶区覆盖。
- TM在旋转方向上的可调节性高于BM,显著影响剂量学结果,使其对肿瘤形态变化更耐受。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: This study evaluates the dosimetric impact of tumor matching (TM) and bone matching (BM) in carbon ion radiotherapy for locally advanced non-small cell lung cancer. MATERIALS AND METHODS: Forty patients diagnosed with locally advanced non-small cell lung cancer were included in this study. TM and BM techniques were employed for recalculation based on re-evaluation computed tomography (CT) images of the patients, resulting in the generation of dose distributions: Plan-T and Plan-B, respectively. These distributions were compared with the original dose distribution, Plan-O. The percentage of the internal gross tumor volume (iGTV) receiving a prescription dose greater than 95% (V95%) was evaluated using dose-volume parameters. Statistical analysis was performed using a paired signed-rank sum test. Additionally, the study investigated the influence of tumor displacement, volume changes, and rotational errors on target dose coverage. RESULTS: The median iGTV V95% values for the Plan-O, Plan-T, and Plan-B groups were 100%, 99.93%, and 99.60%, respectively, with statistically significant differences observed. TM demonstrated improved target dose coverage compared to BM. Moreover, TM exhibited better target coverage in case of larger tumor displacement. TM's increased adjustability in rotation directions compared to BM significantly influenced dosimetric outcomes, rendering it more tolerant to variations in tumor morphology. CONCLUSION: TM exhibited superior target dose coverage compared to BM, particularly in cases of larger tumor displacement. TM also demonstrated better tolerance to variations in tumor morphology.
引用
- Mi J, Jia S, Chen L, et al. Bone matching versus tumor matching in image-guided carbon ion radiotherapy for locally advanced non-small cell lung cancer. Radiat Oncol. 2024. PMID: 39696314. doi:10.1186/s13014-024-02564-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。